Efficacy and Safety of Selexipag in the Treatment of Patients With Inoperable or Persistent/Recurrent CTEPH
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)
Eur. Respir. J. 2024 Oct 01;64(4)2400193, NH Kim, R Channick, M Delcroix, M Madani, J Pepke-Zaba, JI Borissoff, V Easton, S Gesang, D Richard, HA GhofraniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.